Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Hexter Joshua received 284,746 Oramed Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Hexter Joshua (COO & CBO) received 284,746 Oramed Pharmaceuticals Inc. shares as an award, leaving 1,358,130 shares. Filed Sep 25, 2026 (Form 4).
- Awarded
- 284,746 shares
- Holding after
- 1,358,130 shares
- Trading plan
- No
- Role
- COO & CBO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Award | 75,455 | 1,148,839 | Direct | |
| Sep 24, 2026 | Common Stock | Award | 209,291 | 1,358,130 | Direct |
Source
Related
- Oramed Pharmaceuticals Inc.
- Hexter Joshua
- Oramed Pharmaceuticals Inc. shareholders
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Hexter Joshua · Jul 2, 2026
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026
- Form 4 · Gabay Avraham · Sep 25, 2026
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026